CISEN(SH:603367) Xin Lang Cai Jing·2025-11-19 03:24Group 1 - The core point of the news is that Chenxin Pharmaceutical's stock price dropped by 5.13% to 19.59 CNY per share, with a trading volume of 279 million CNY and a turnover rate of 3.08%, resulting in a total market capitalization of 8.869 billion CNY [1] - Chenxin Pharmaceutical, established on November 6, 1998, and listed on September 29, 2017, is primarily engaged in the research, development, and production of chemical drug formulations [1] - The company's main revenue sources are: large-volume infusion (42.66%), small-volume injectables (29.80%), oral solid preparations (13.98%), drops (4.31%), lyophilized powder injections (3.68%), ointments (3.43%), raw materials (1.35%), rinsing agents (0.59%), and others (0.20%) [1] Group 2 - Among the top circulating shareholders of Chenxin Pharmaceutical, Ping An Fund's Ping An Medical Health Mixed A (003032) entered the top ten in the third quarter, holding 3.8777 million shares, accounting for 0.86% of the circulating shares, with an estimated floating loss of approximately 4.1104 million CNY [2] - Ping An Medical Health Mixed A (003032) was established on November 24, 2017, with a latest scale of 2.028 billion CNY, achieving a year-to-date return of 63.9% and ranking 315 out of 8138 in its category [2] - The fund manager of Ping An Medical Health Mixed A is Zhou Sicong, who has a cumulative tenure of 11 years and 314 days, with the fund's total asset size at 5.51 billion CNY and a best return of 104.39% during his tenure [3]